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Abstract
Background: Cells of tissues and biofilm forming bacteria compete for the living space on the surface of an
implant. We hypothesized the incubation of the implant (titanium, polydimethylsiloxane, and polystyrene
surface) with human cells before implantation as a strategy to prevent bacterial adhesion and biofilm formation.
Methods: After 24 hours of incubation with human osteogenic sarcoma SaOS-2 cells (1 · 105 cells/mL), the
materials were incubated for 4.5 hours or two days with Staphylococcus aureus in serial 1:10 dilutions of 108
colony-forming units/mL. The bacterial adherence and biofilm biomass on materials pre-incubated with SaOS-2
cells were compared with our previous results on materials incubated only with bacteria or in simultaneous co-
culture of SaOS-2 cells and S. aureus. Fluorescent microscopy and crystal violet stain were used. The number of
viable SaOS-2 and bacterial cells present was tested using colorimetric methods (MTT, LDH) and drop plate
method, respectively.
Results: The pre-treatment with human cells was associated with a reduction of bacterial colonization of the
biomaterial at 4.5 hours and 48 hours compared with the non-pre-treated materials. The presence of bacteria
decreased the number of viable human cells on all materials. (Supplementary Fig. 1; see online supplementary
materials at www.liebertpub.com/sur).
Conclusions: These results suggest that the pre-operative incubation of prostheses with host cells could prevent
infection of biomaterials.
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The two leading causes of failure for prosthesesare aseptic loosening and prosthetic infection. With the
increased number of implantations, the absolute number of
complications is increasing inevitably [1–3]. The presence of a
foreign body automatically initiates the race between bacteria
and host cells to colonize the surface of the implant [4]. Bac-
teria that adhere to implanted medical devices or to damaged
tissue form a thin layer known as a biofilm [5]. The ability to
grow in a biofilm form enables the bacteria to protect them-
selves from host defense, antibiotic agents, and biocides,
making it difficult to manage these infections; thus, it requires
long periods of antibiotic therapy and often repeated surgical
procedures, all leading to a clinical and economic burden [5–7].
Research on anti-biofilm implant properties focuses on
materials loaded or coated with anti-adhesive/anti-bacterial
substances or surfaces with nanostructures [8–13]. Active
coatings release pre-incorporated bactericidal agents such as
antibiotic agents, antiseptics such as silver ions or growth
factors, chemokines, and peptides that prevent the infection.
The spread of some of these substances into the neighboring
tissues, however, could provide a consequent risk of inducing
bacterial resistance or cytotoxicity [14]. The most recent
approaches, so-called passive coatings, appear promising,
because they diminish the rate of infections by enhancing
tissue compatibility or integration, or by directly inhibiting
bacterial adhesion [15–17].
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Adherence and colonization by either bacterial cells or
tissue cells on biomaterials have been studied mainly as
separate phenomena [1,8,9,18]. During the development of
new biomaterial coating strategies, however, these two issues
must be evaluated in parallel, because it is essential to
achieve a successful long-term outcome. According to our
previous study, in the race between bacteria and tissue cells
for the implant surface, the presence of either one reduces
biomaterial adhesion and the viability of the other, which
implies that host-cell integration on implant surfaces reduces
bacterial contamination [19].
Micro-organisms frequently infect an implant surface
during surgical procedures and start to compete for the sur-
face before tissue integration [20]. We hypothesized that
incubation of implants with host cells before implantation
may be a way to reduce the living space available for the
bacteria and would thus help to avoid the bacterial adhesion
and consequently the infection of biomaterials, eluding the
use of antibiotic-loaded biomaterials, which confers a risk for
bacterial antibiotic resistance [21,22].
Methods
Materials
Magnetron sputtering technique was used for deposition of
titanium samples as described previously [9]. The 2-mm
thick bulk polydimethylsiloxane (PDMS) polymer sheets of
size 9 · 9mm were obtained from a commercial supplier
of industrial polymers (ETRA, Helsinki, Finland). Average
surface roughness Ra was approximately 300–400 nm for
both materials. The 24-well cell culture plates of polystyrene
(PS) (Thermo Scientific Nunc, Roskilde, Denmark) were
used as control material.
Co-culture of human cells and staphylococci
Culture of human cells. Human osteosarcoma SaOS-2
cells (ECACC, Salisbury, Wiltshire, UK) were grown as de-
scribed by Perez-Tanoira et al. [19]. Human cells were seeded at
105 cells/mL on (a) titanium, (b) PDMS, and (c) directly on
24-well PS cell culture plates and were incubated in a total
volume of 2mL of MEM (minimal essential medium) sup-
plemented with 10% heat-inactivated fetal bovine serum
(FBS) and 1% l-glutamine (Life Technologies, Grand Is-
land, NY) containing 500 IU/mL penicillin and 0.1mg/mL
streptomycin for 24 hours at +37C in 20% or 6% O2 in a
humidified incubator.
Culture of staphylococci. Staphylococcal adhesion ex-
periments were performed as described by Kinnari et al. [12].
The S. aureus 15981 [23] isolated at the Microbiology De-
partment of the University Clinics of Navarra, Spain, was se-
lected because it has a strong biofilm production phenotype
and a well-described antibiotic susceptibility profile. Bacteria
were diluted in sterile 10mMphosphate-buffer saline (PBS) to
obtain suspension with a 108 colony-forming unit (CFU)/mL.
The optical density of the bacterial suspension was measured
at a wavelength of 550 nmwith a spectrophotometer according
to the McFarland standard (BioMerieux, SA Lyon, France).
Co-culture of human cells and staphylococci. Serial 1:10
dilutions were made from 108 CFU/mL S. aureus suspension
to obtain the bacterial concentrations of 107, 106, 105, 104,
103, and 102 CFU/mL in a total volume of 2mL ofMEM:PBS
(1:1), MEM including 5% FBS, 0.5% l-glutamine (Life
Technologies). Based on our previous study [19], MEM:PBS
medium was chosen to be used in the studies. The different
bacterial dilutions were incubated for 4.5 or 48 hours on (a)
titanium, (b) PDMS, and directly on (c) 24-well PS cell
culture plates. In the simultaneous co-culture, the studied
biomaterial surfaces were maintained in the same medium
simultaneously with 105SaOS-2 cells/mL [19]. In the case of
materials pre-incubated with SaOS-2 cells, after the cell
medium was removed and samples were washed three times
with PBS to remove any non-adherent human cell, they were
on the same S. aureus media.
A negative control (1mL of PBS +1mL of MEM), bac-
terial control (1mL of 108 CFU/mL of S. aureus on PBS
+1mL of MEM), a cellular control (1mL of 105cells/mL on
MEM +1mL of PBS after 4.5 hours, [24 + 4.5] hours,
48 hours, or (24+ 48) hours) were also included. In each
experiment, a total of 10 samples of titanium, PDMS, and
well plates were covered with each of the different dilutions,
and incubated first for 4.5 hours at 37C to allow cell and
bacterial adhesion and then up to 48 hours for biofilm for-
mation and cell adhesion in a static model.
Assessment of cell proliferation and cytotoxicity
Fluorescence microscopy. After incubation with the
different dilutions of bacteria and human cells, samples
were washed three times with PBS. The dried plates were
stained for two minutes with a rapid fluorescence staining
method using Acridine Orange (BD Diagnostics, Sparks,
MD). Images were taken with a fluorescent light Leica
DM6000 B/M research microscope (Leica Microsystems,
Wetzlar, Germany) equipped with Leica DFC420 digital
camera (Leica Microsystems), with 10 ·magnification and
identical settings and parameters for photographing of all
samples. On each plate, eight fields were viewed and pho-
tographed. All experiments were performed in triplicate.
Assay for SaOS-2cell viability. Human cell viability was
assessed by 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium
bromide tetrazolium (MTT) dye assay based on mitochon-
drial ability to transform soluble MTT to its insoluble purple
product, formazan. After 4.5 hours or 48 hours, culture me-
dium was replaced by 10 mcL of 5mg/mL MTT (EMD
Millipore Corp., Billerica, MA) dissolved in dimethyl sulf-
oxide (DMSO) (MP Biomedicals, LLC, Illkirch, France) for
four hours. Then, cells were suspended by adding 300 mcL of
detergent reagent at +22C during two hours. Aliquots of
200 mcL were then transferred to 96-well plates for mea-
surement of absorbance using CHAMELEON V Multilabel
Microplate Reader (Hidex, Turku, Finland) with 570 nm test
and 690 nm reference wavelengths.
Lactate dehydrogenase (LDH) cytotoxicity assay. Cyto-
toxicity was determined by assessing the release of cyto-
solic enzyme LDH into the supernatant medium. The LDH
assay was performed using tetrazolium dye-based CytoTox
96 Non-Radioactive Cytotoxicity Assay (Promega, Madison,
WI) according to the manufacturer’s instructions. Super-
natants (experimental LDH release), samples treated with the
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lysis solution (maximal LDH release), and non-treated con-
trol samples (spontaneous LDH release) were transferred to
96-well plates. The absorbance at 490 nm was read using a
microplate reader. Percentage of cytotoxicity values was
calculated using the formula (100· [experimental LDH
release – spontaneous LDH release/maximum LDH release-
spontaneous release]) [24].
Bacterial adherence and biofilm formation
Bacterial adherence and biofilm formation results obtained
in this study from materials pre-incubated with SaOS-2 cells
during 24 hours were compared with results of our earlier
study obtained from materials incubated with S. aureus only
or in a co-culture with SaOS-2 cells [19]. After 4.5 hours and
48 hours incubation time, samples were washed three times
with 250 mcL of PBS to remove non-adherent bacteria and
cells, followed by treatment with 400 mcL of trypsin. To
compare the results, all the materials, incubated or not with
SaOS-2 cells, were treated with trypsin to take into consid-
eration the possible effect of trypsin. Controls were per-
formed simultaneously with the tests to avoid bacterial
adaptation to laboratory conditions.
Drop plate method. All materials were sonicated in an
ultrasonic bath USC100T (VWR, Leuven, Belgium) at
45 kHz with a power output of 300W for five minutes in
2.5mL of PBS as described earlier [25,26]. The number of
viable bacteria in each sonication product was quantified by
the drop plate method [27]. The bacterial count obtained from
co-cultures was compared with the results of bacterial mono-
cultures. The experiments were all performed in sets of three.
Crystal violet. Based on the methods of Pitts et al. [28]
and Stepanovic et al. [29], at the end of the incubation period,
each material was washed to remove all non-adherent bac-
teria. The remaining attached bacteria were stained for 15
minutes with 1% crystal violet stain. Excess stain was rinsed
off by placing the plate under running tap water. The dye
bound to the adherent cells was re-dissolved in 300 mcL
of 95% ethanol. Aliquots of 200 mcL were then transferred
to 96-well plates for measurement of absorbance using
Chameleon-V microplate reader with 570 nm (test) and 690 nm
(reference) wavelengths.
Statistical analysis
The statistical analyses were performed with four inde-
pendent experiments per test condition. The data are reported
as (mean – standard deviation [SD]). Data were analyzed
using IBM SPSS Statistics for Windows Version 22.0 soft-
ware (IBM Corp., Armonk, NY). Non-parametric tests were
used. Mann-Whitney or Wilcoxon tests were used for two
samples, and the Kruskal-Wallis test was used for more than
two samples.
Results
Effects of bacterial exposure on number
of viable cells and on cytotoxicity
Figure 1 shows representative images of the titanium
surfaces incubated with human cells for 4.5 hours or 48 hours
in the presence or absence of bacteria. When SaOS-2 cells
were pre-incubated with the biomaterial for 24 hours before
addition of bacteria, the number of attached S. aureus on
biomaterials was clearly lower than with the same bacterial
density without cells (panels a and f), or when cells and
bacteria were added simultaneously (b and g). The data of
panels (a, b, c, f, g, and h) are presented for comparison and
are obtained from our previous study [19]. When bacteria
were added, the number of viable SaOS-2 cells on biomate-
rial was significantly reduced both in simultaneous co-culture
(panels b and g) and materials pre-incubated with SaOS-2
cells (panels d and i), as compared with SaOS cells incubated
alone, both after 4.5 and 48 hours of culture (panels c, e, h,
and j).
The results were confirmed for all bacterial densities by
using MTT proliferation assay. The reduction was not af-
fected by the bacterial density for PS (p= 0.685 and p = 0.100,
Kruskal-Wallis test, for 4.5 hours and 48 hours, respectively)
or PDMS (p = 0.158 and 0.246 for 4.5 hours and 48 hours,
respectively). This was visible on the titanium surface,
however, where CFU/mL >106 diminished number of viable
SaOS-2 cells compared with CFU = 102. There were no sta-
tistically significant differences on number of attached hu-
man cells on titanium surfaces for CFU = 103-108 (p= 0.187
and 0.550 for 4.5 hours and 48 hours, respectively).
Figure 2 shows a statistically significant reduction of the
percentage of viable SaOS-2 cells after 48 hours compared
with 4.5 hours for all bacterial densities and materials with
respect to the materials incubated only with SaOS-2 cells.
Bacteria were cytotoxic to the pre-incubated SaOS-2 cells
as evidenced by increased LDH release from cells on all
materials studied (Fig. 3). Cytotoxicity was not dependent of
the bacterial density for PS (p= 0.494 and p = 0.275 for
4.5 hours and 48 hours, respectively) and PDMS (p= 0.361
and p= 0.457 for 4.5 hours and 48 hours, respectively). Only
in the case of cells incubated on titanium for 4.5 hours, the
presence of S. aureus CFU/mL ‡106 increased the death of
SaOS-2 cells (p= 0.388 for CFU/mL = 102-105 after 4.5 hours
and p = 0.382 for CFU/mL = 102-108 after 48 hours). On the
other hand, the percentage of cell cytotoxicity after 48 hours
was higher compared with the same bacterial density and
materials after 4.5 hours, only with the exception of titanium
for CFU ‡107 (p = 0.248 for CFU/mL = 107-108).
Incubation of biomaterial with human SaOS-2
cells reduces the viability of bacterial cells
and the biofilm formation
The pre-incubation of prosthetic materials with SaOS-2
cells reduced bacterial adherence and biofilm biomass com-
pared with the materials incubated only with bacteria or with
simultaneous co-culture with S. aureus and SaOS-2 cells as
detected by crystal violet. This was observed with all bac-
terial concentrations with the exception of simultaneous co-
culture at 4.5 hours, on PS with CFU/mL ‡107 (p = 0.080 and
0.561 with CFU/mL = 107 and 108, respectively), and tita-
nium with CFU/mL = 108 (p = 0.081) and at 48 hours on PS
with CFU/mL = 108 (p = 0.149) (Fig. 4).
As demonstrated in Figure 5, the amount of viable bacteria
in all materials and with different concentrations of bacteria
was reduced by the pre-incubation with SaOS-2 as compared
with the materials incubated only with S. aureus or in si-
multaneous co-culture (Fig. 5).
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Discussion
The present findings support the hypothesis that pre-
operative incubation of biomaterial with osteoblast host cells
could prevent infection of the biomaterial. We found that
in vitro, after tissue cells have adhered to the surface of the
biomaterial, bacteria cells are more unlikely to displace them.
This seems to prevent the colonization of the implant surface
with circulating planktonic bacteria that can lead to biofilm
development. Otherwise, within the high dense bacterial
population, efficient horizontal transfer of resistance and
virulence genes takes place leading to the spread of resistance
to conventional antibiotic therapies necessitating the use of
alternative agents [30,31].
Much of the recent research work in this field has focused
on the design of coatings that prevent infection while ig-
noring bone mineralization or vice versa [1]. The promotion
of tissue integration as a mean of protection against infection
has been poorly studied [32,33]. According to Subbiahdoss
et al. [33], if an implant is integrated rapidly by the tissue to
levels above critical cell surface coverage, it will be protected
effectively against post-operative contaminating bacteria.
Dexter et al. [32], who considered separately the presence of
human cells and bacteria, suggested that by controlling
the density of proteins or ligands on a surface, cell adhe-
sion and surface coverage could be stimulated without
stimulating bacterial adhesion, hence reducing the likeli-
hood of infection.
FIG. 1. Representative fluorescence microscope images of titanium surface incubated with 108 colony-forming units (CFU)/
mL of Staphylococcus aureus (a), simultaneous co-culture of 105 SaOS-2 cells/mL and S. aureus (b), or 105 SaOS-2 cells/
mL (c) for 4.5 hours or for 48 hours (f–h). Panels d,e and i,j had similar conditions except that SaOS-2 cells had been pre-
incubated for 24 hours before adding S. aureus. Incubation times in d,e were 4.5 hours and in i,j, they were 48 hours. The
samples were stained with Acridine Orange (BD Diagnostics, Sparks, MD).
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Our results are in good agreement with the important
implication of these findings. Because micro-organisms are
frequently introduced on an implant surface during surgery,
however, they start the race for the surface with an ad-
vantage. We decided to try to prevent the peri-operative
contamination by adhering the human cells to the surface
before contamination [34].
We need to develop strategies in which bacterial adhesion
on biomaterial is avoided; less than102 CFU of S. aureus is
needed to develop biofilm in an implant and establish a
FIG. 2. Percentage of viable SaOS-2 cells pre-incubated for 24 hours (measured by MTT assay) on polystyrene, titanium,
and polydimethylsiloxane in the presence or absence of different concentrations of Staphylococcus aureus after incubation of
4.5 hours and 48 hours. Results are means– standard deviation of four determinations in quadruplicate culture. *Statistically
significant means p< 0.05 for 4.5 hours compared with 48 hours unless otherwise mentioned. CFU= colony-forming units.
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FIG. 3. Lactate dehydrogenase activity levels of media of SaOS-2 pre-incubated for 24 hours on polystyrene, titanium,
and polydimethylsiloxane in the presence or absence of different concentrations of Staphylococcus aureus after 4.5 hours or
48 hours. Results are means – standard deviation of four determinations in quadruplicate culture. *Statistically significant
means p < 0.05 for 4.5 hours compared with 48 hours unless otherwise mentioned. CFU = colony-forming units.
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prosthesis infection [35,36]. Several studies have shown a
reduction of bacterial adherence at high bacterial densities,
CFU/mL ‡106; however, the clinical relevance of such high
bacterial densities may be questionable. We found that at
longer incubation times, the presence of bacteria produces a
higher decrease of osseointegration. We tested serial 1:10
dilutions from 102 CFU/mL up to 108 CFU/mL. Our results
show a biomaterial-associated infection prevention by pre-
operative incubation with human cells when materials are
contaminated with bacterial density related to clinical cir-
cumstances (102-104 CFU/mL).
Starting from the lowest bacterial density, the presence of
S. aureus diminished osteoblast viability and proliferation,
even when bacteria were not detected or isolated from the
surface of the implant. The fact that it was not dependent of
the bacterial density, however, is in agreement with our
previous study [19], while it contrasts with that of Sub-
biahdoss et al. [33], who found that once cell surface cov-
erage exceeded a critical value, contaminating bacteria
ceased to negatively affect cell growth.
These results are not conclusive, but we think this study
can be used as a proof of concept. One question, still
unanswered, is how the pre-operative incubation with
autologous osteoblast cells affects the tissue integration of
the implant. In the future, we will assess the use of pri-
mary osteoblast cells. Compared with SaOS-2 cells, longer
FIG. 4. Absorbance value of crystal violet assay after 4.5 hours and 48 hours incubation. Mean and standard deviation are
shown. *Statistically significant means p < 0.05 versus all other situations unless otherwise mentioned. CFU = colony-
forming units.
FIG. 5. Colony-forming units as determined by viable cell count after 4.5 hours and 48 hours incubation. Mean and
standard deviation are shown. *Statistically significant means p < 0.05 versus all other conditions unless otherwise men-
tioned. CFU = colony-forming units.
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pre-incubation time will be required with primary cells to
obtain coverage of most of the surface area of the implant.
Future research will involve the effects of phagocytosis,
considering the presence of macrophages in co-culture
with bacteria and osteoblasts. These findings could also be
proved using clinically significant bacterial strains isolated
from prosthetic infections, which may show more viru-
lence against human cells.
Implant infection is a rising problem especially in devices
implanted to bone contact such as in orthopedic, maxillofa-
cial, and ear surgical procedures. The implantation to bone
contact is increasing and involves patients of all ages. We
tested materials mainly used in bone contact, despite the fact
that the rate of infection is lower compared with implants
used elsewhere [1]. In the next stages of our research, it
would be interesting to investigate whether biomaterials such
as polytetrafluoroethylene that are used more for soft tissue
implantation would show similar prevention of infection
when pre-operatively incubated with cells from soft tissue
such as fibroblasts.
Conclusions
The concept of tissue integration over microbial coloni-
zation provides an important guideline for which ‘‘in vitro’’
assays may be indispensable tools and should be part of the
development process of any tissue engineered constructs and
devices [37]. It can be argued that the prevention of bacterial
adhesion without drugs, through pre-operative incubation of
prostheses with host cells, may be one of the most effective
ways to reduce biomaterial infections.
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